A recent study reveals that IL-33 stimulates ILC2 to secrete amphiregulin to promote tissue repair in experimental colitis (42), suggesting ILC2 at different stage of the disease and/or some subset of ILC2 (i.e., amphiregulin+ ILC2) may have protective function in the resolution of colitis as well. Here, AREG is linked to colitis.